Clinical Trial Update: Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated AngioJet rheolytic thrombectomy for massive pulmonary embolism and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• AngioJet rheolytic thrombectomy device

Snippet

Sponsor: University Hospital, Geneva | Conditions: Pulmonary Embolism | Phase 2 | Status: COMPLETED